Asymchem Laboratories (Tianjin) Co., Ltd. (SHE: 002821)

Market Cap	26.24B
Revenue (ttm)	5.57B
Net Income (ttm)	769.03M
Shares Out	354.88M
EPS (ttm)	2.16
PE Ratio	35.20
Forward PE	19.84
Dividend	1.80 (2.37%)
Ex-Dividend Date	n/a

Volume	3,620,356
Open	77.41
Previous Close	78.55
Day's Range	75.87 - 78.76
52-Week Range	59.55 - 116.22
Beta	0.17
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 29, 2025

About Asymchem Laboratories (Tianjin)

Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers process development and optimization, analytical, and scale-up services for small molecule drug products throughout the pre-clinical and clinical stage; and ton-scale manufacturing services for registered starting materials, advanced intermediates, and active pharmaceutical ingredients. It also engages in pre-formulation and formulation development; provision of chemical m...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 9,788
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002821

Financial Performance

In 2023, Asymchem Laboratories (Tianjin)'s revenue was 7.83 billion, a decrease of -23.70% compared to the previous year's 10.26 billion. Earnings were 2.27 billion, a decrease of -31.28%.